https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34393 Wed 09 Mar 2022 16:03:55 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54623 Wed 06 Mar 2024 10:51:58 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34285 Wed 06 Apr 2022 13:57:14 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:22049 Sat 24 Mar 2018 07:15:53 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:22044 Chlamydia, Haemophilus influenzae and Streptococcus pneumoniae in early life may promote permanent deleterious changes in immunity, lung structure, and function that predispose to, or increase the severity of chronic respiratory diseases in later life. For example, these infections increase immune responses, which drive subsequent asthma pathogenesis. Targeting the pathways involved with specific inhibitors or agonists may prevent these consequences of early-life infection. Vaccination and immunomodulatory therapies that control the infections and their sequelae may also be efficacious.]]> Mon 01 Feb 2016 13:04:15 AEDT ]]>